We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 81-100 of 10,000 results
  1. Benefits of Trimodality Therapy Compared with Systemic Therapy Alone in Male Patients with Stage IV Breast Cancer

    Background

    Male breast cancer (MBC) represents <1% of all breast cancer (BC) diagnoses. Recent publications in female stage IV BC have shown that...

    Kelly A. Stahl, William Wong, ... Chan Shen in Annals of Surgical Oncology
    Article 03 September 2021
  2. Photobiomodulation Therapy: A New Light in the Treatment of Systemic Sclerosis Skin Ulcers

    Introduction

    Skin ulcers (SU) represent one of the most frequent manifestations of systemic sclerosis (SSc), occurring in almost 50% of scleroderma...

    Amelia Spinella, Marco de Pinto, ... Dilia Giuggioli in Rheumatology and Therapy
    Article Open access 25 March 2022
  3. The preoperative systemic immune-inflammation index is associated with an unfavorable prognosis for patients undergoing curative resection of esophageal squamous cell carcinoma after neoadjuvant therapy

    Purposes

    Systemic inflammation and immune status play a critical role in the development and progression of cancers. We evaluated the clinical...

    Yuma Obata, Mitsuro Kanda, ... Yasuhiro Kodera in Surgery Today
    Article 16 February 2023
  4. Association of systemic inflammation with shock severity, 30-day mortality, and therapy response in patients with cardiogenic shock

    Background

    Mortality in cardiogenic shock (CS) remains high even when mechanical circulatory support (MCS) restores adequate circulation. To detect a...

    Angela Dettling, Jessica Weimann, ... Benedikt Schrage in Clinical Research in Cardiology
    Article Open access 20 November 2023
  5. Outcome of patients with biochemical recurrence of prostate cancer after PSMA PET/CT-directed radiotherapy or surgery without systemic therapy

    Background

    Radiotherapy (RT) and surgery are potential treatment options in patients with biochemical recurrence (BCR) following primary prostate...

    Sara Harsini, Don Wilson, ... François Bénard in Cancer Imaging
    Article Open access 17 March 2023
  6. Systemic therapy for early-stage breast cancer: learning from the past to build the future

    The treatment of breast cancer has improved dramatically over the past century, from a strictly surgical approach to a coordinated one, including...

    Elisa Agostinetto, Joseph Gligorov, Martine Piccart in Nature Reviews Clinical Oncology
    Article 17 October 2022
  7. Real-World Effectiveness of Newly Initiated Systemic Therapy for Atopic Dermatitis in the United States: A Claims Database Analysis

    Introduction

    Atopic dermatitis (AD) is associated with significant quality-of-life and economic burdens. Real-world evidence is needed to identify...

    Jashin J. Wu, Marie-Hélène Lafeuille, ... Marco DiBonaventura in Advances in Therapy
    Article Open access 12 July 2022
  8. The therapeutic effect of radiotherapy combined with systemic therapy compared to radiotherapy alone in patients with simple brain metastasis after first-line treatment of limited-stage small cell lung cancer: a retrospective study

    Purpose

    We aimed to compare the therapeutic effect of radiotherapy (RT) plus systemic therapy (ST) with RT alone in patients with simple brain...

    **nyu Gao, Tingting Liu, ... Wei Huang in World Journal of Surgical Oncology
    Article Open access 10 April 2024
  9. Ceftazidime-avibactam combination therapy versus monotherapy for treating carbapenem-resistant gram-negative infection: a systemic review and meta-analysis

    Background

    This meta-analysis was conducted to compare the efficacy of ceftazidime-avibactam combination therapy with that of monotherapy in the...

    Wei Hsu, Min-Hsiang Chuang, ... Hung-Jen Tang in Infection
    Article 13 May 2024
  10. TIPS plus sequential systemic therapy of advanced HCC patients with tumour thrombus-related symptomatic portal hypertension

    Objectives

    Portal vein tumour thrombus (PVTT)–related symptomatic portal hypertension (SPH) leads to a poor prognosis in hepatocellular carcinoma...

    Zhenkang Qiu, Guobao Wang, ... Fei Gao in European Radiology
    Article Open access 20 April 2022
  11. Clinical features and response to systemic therapy in NRAS-mutant Chinese melanoma patients

    Purpose

    The prognosis of patients with NRAS-mutant melanoma is rather poor. Immunotherapy and targeted therapy have revolutionized anti-tumor therapy,...

    Jiuhong Wang, Hang Jiang, ... **g**g Li in Journal of Cancer Research and Clinical Oncology
    Article 01 December 2022
  12. [177Lu]Lu-PSMA-617 as first-line systemic therapy in patients with metastatic castration-resistant prostate cancer: a real-world study

    Purpose

    The use of [ 177 Lu]Lu-PSMA-617 radioligand therapy has become increasingly recognized as a viable therapeutic approach for patients in the...

    Swayamjeet Satapathy, Madhav Prasad Yadav, ... Chandrasekhar Bal in European Journal of Nuclear Medicine and Molecular Imaging
    Article 12 March 2024
  13. Real-world systemic sequential therapy with regorafenib for recurrent hepatocellular carcinoma: analysis of 93 cases from a single center

    Background

    Regorafenib is an oral multikinase inhibitor and became the first second-line systemic treatment for hepatocellular carcinoma (HCC)...

    Qingwei Zhu, Wei Rao, ... Liqun Wu in BMC Gastroenterology
    Article Open access 01 February 2023
  14. Systemic immune-inflammation index predicts the clinical outcomes in patients with acute uncomplicated type-B aortic dissection undergoing optimal medical therapy

    Background

    Optimal medical therapy (OMT) for uncomplicated type B aortic dissection (uTBAD) provides excellent short-term outcomes during follow up;...

    Ruirong Chen, Sheng Su, ... Jianfang Luo in BMC Cardiovascular Disorders
    Article Open access 02 January 2024
  15. Effect and safety profile of belimumab and tacrolimus combination therapy in thirty-three patients with systemic lupus erythematosus

    Introduction/objectives

    Belimumab combined with mycophenolate mofetil has been proven to be effective for treating systemic lupus erythematosus (SLE)...

    Takehiro Nakai, Sho Fukui, ... Masato Okada in Clinical Rheumatology
    Article 08 August 2022
  16. A Preliminary Examination of the Effects and Mechanisms of Cognitive Behavioral Therapy for Insomnia on Systemic Inflammation Among Patients with Knee Osteoarthritis

    Background

    Systemic inflammation, particularly the elevation of interleukin-6 (IL-6), plays an important role in the maintenance and progression of...

    Chung Jung Mun, Traci J. Speed, ... Michael T. Smith in International Journal of Behavioral Medicine
    Article 25 May 2023
  17. Pregnancy outcomes in patients receiving assisted reproductive therapy with systemic lupus erythematosus: a multi-center retrospective study

    Objectives

    To evaluate the safety, efficacy, and maternal and fetal outcomes of assisted reproductive therapy (ART) in systemic lupus erythematosus...

    Minxi Lao, Peiyin Dai, ... Dongying Chen in Arthritis Research & Therapy
    Article Open access 25 January 2023
  18. Validation of prognostic and predictive value of total tumoral load after primary systemic therapy in breast cancer using OSNA assay

    Purpose

    This study aimed to validate the classification of breast cancer (BC) patients in progression risk groups based on total tumor load (TTL)...

    Laia Bernet-Vegué, Carolina Cantero-González, ... María Dolores Martín-Salvago in Clinical and Translational Oncology
    Article Open access 09 December 2023
  19. Tocilizumab Therapy for Treatment-Resistant Systemic Lupus Erythematosus with Elevated IL-6 and CRP Levels: a Case Report

    Systemic lupus erythematosus (SLE) is a complex autoimmune disease with variable clinical manifestations and treatment responses. Different cytokines...

    Sandeep Yadav, Vishnu Sharma, C. Balakrishnan in SN Comprehensive Clinical Medicine
    Article 05 August 2023
  20. Trends and drivers of pharmaceutical expenditures from systemic anti-cancer therapy

    Expenditures on medicine for systemic anti-cancer therapy (SACT) have seen large increases in recent years. The characterization of patients with...

    Lars Børty, Rasmus F. Brøndum, ... Martin Bøgsted in The European Journal of Health Economics
    Article 26 August 2022
Did you find what you were looking for? Share feedback.